Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LAM RESEARCH CORPLRCX · Entity 1467 | Vice President | December 14, 2010 | December 16, 2010 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LAM RESEARCH CORP
Report date December 14, 2010 · Filed December 16, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2010-12-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2010-12-14 · Conversion · Acquired 5,000 · Balance 0 |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2010-12-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2010-12-14 · Sale · Disposed 2,500 · Balance 0 F2: Shares sold pursuant to 10b5-1 Trading Plan. |
| Common StockSEC Table I · non-derivative | Direct | 34,505 |
Reported balance
After 2010-12-14 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2010-12-14 · Sale · Disposed 2,500 · Balance 34,505 F2: Shares sold pursuant to 10b5-1 Trading Plan. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.47 · Expires 2011-08-06 | Direct | 26,040 |
Reported balance
After 2010-12-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2010-12-14 · Exercise / conversion · Disposed 5,000 · Balance 26,040 F1: Stock option was 100% vested on 06/24/05. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock option was 100% vested on 06/24/05.
F2: Shares sold pursuant to 10b5-1 Trading Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2010 Filed Dec 16, 2010 19:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $29.47 Strike: $29.47 | $147,350.00 |
DisclosureSEC source: 0001392425-10-000002 · primary_doc.xml · derivative · entry 4 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,040 Underlying: Common Stock · 5,000 shares Expires 2011-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option was 100% vested on 06/24/05. Read SEC document |
| December 14, 2010 Filed Dec 16, 2010 19:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 2,500 | $52.75 | $131,875.00 |
DisclosureSEC source: 0001392425-10-000002 · primary_doc.xml · nonDerivative · entry 3 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,505 F2 · security: Shares sold pursuant to 10b5-1 Trading Plan. Read SEC document |
| December 14, 2010 Filed Dec 16, 2010 19:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 2,500 | $52.38 | $130,950.00 |
DisclosureSEC source: 0001392425-10-000002 · primary_doc.xml · nonDerivative · entry 2 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Shares sold pursuant to 10b5-1 Trading Plan. Read SEC document |
| December 14, 2010 Filed Dec 16, 2010 19:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | ConversionCommon Stock | 5,000 | $29.47 | $147,350.00 |
DisclosureSEC source: 0001392425-10-000002 · primary_doc.xml · nonDerivative · entry 1 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2010 Filed Feb 9, 2010 19:45 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 13,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001392425-10-000001 · primary_doc.xml · nonDerivative · entry 1 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,879 Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 01:05 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantStock Option (right to buy) · Derivative | 24,740 | $20.21 Strike: $20.21 | $499,995.40 |
DisclosureSEC source: 0001392425-09-000001 · primary_doc.xml · derivative · entry 2 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,040 Underlying: Common Stock · 24,740 shares Expires 2014-02-26 F1 · derivative.exercise_date: 100% of the option will vest and become exercisable on 2/26/11. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 01:05 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 9,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001392425-09-000001 · primary_doc.xml · nonDerivative · entry 1 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,229 Read SEC document |
| December 01, 2008 Filed Dec 3, 2008 22:13 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 595 | $19.07 | $11,346.65 |
DisclosureSEC source: 0001392425-08-000003 · primary_doc.xml · nonDerivative · entry 1 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,333 Read SEC document |
| August 01, 2008 Filed Aug 6, 2008 01:31 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 595 | $32.60 | $19,397.00 |
DisclosureSEC source: 0001392425-08-000001 · primary_doc.xml · nonDerivative · entry 1 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,431 Read SEC document |
| May 01, 2008 Filed Sep 26, 2008 22:40 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantStock Option (right to buy) · Derivative | 3,500 | Not disclosed Strike: $25.53 | Not disclosed |
DisclosureSEC source: 0001392425-08-000002 · primary_doc.xml · derivative · entry 2 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,800 Underlying: Common Stock · 3,500 shares Expires 2009-02-27 F1 · kind: On 02/27/02 the reporting person was granted an option to purchase 15,000 shares of the Issuer's Common Stock at a purchase price of $22.05 per share. This option had an exercise price which was less than the closing price of the company's common stock on the appropriate measurement date determined by a special committee of the company's Board of Directors and the Company for financial accounting purposes. The Company has agreed to amend the outstanding portion of the misdated option to increase the exercise price to the appropriate fair market value per share on the correct measurement date ($25.53) so as to avoid adverse tax consequences under Internal Revenue Code 409A, and as applicable, similar provisions of state law. The Company and the reporting person entered into a Stock Option Amendment and Special Bonus Agreement to amend this option. F1 · price: On 02/27/02 the reporting person was granted an option to purchase 15,000 shares of the Issuer's Common Stock at a purchase price of $22.05 per share. This option had an exercise price which was less than the closing price of the company's common stock on the appropriate measurement date determined by a special committee of the company's Board of Directors and the Company for financial accounting purposes. The Company has agreed to amend the outstanding portion of the misdated option to increase the exercise price to the appropriate fair market value per share on the correct measurement date ($25.53) so as to avoid adverse tax consequences under Internal Revenue Code 409A, and as applicable, similar provisions of state law. The Company and the reporting person entered into a Stock Option Amendment and Special Bonus Agreement to amend this option. F3 · price: In exchange for increasing the exercise price of this misdated option, the company agreed to make a cash payment in January of 2009 to the reporting person, in order to make such reporting person whole for the incremental exercise price increase. The amount of the cash payment is expected to be $12,180. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 01, 2008 Filed Sep 26, 2008 22:40 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerStock Option (right to buy) · Derivative | 3,500 | Not disclosed Strike: $22.05 | Not disclosed |
DisclosureSEC source: 0001392425-08-000002 · primary_doc.xml · derivative · entry 1 Bondur Thomas J · CIK 0001392425 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2009-02-27 F1 · kind: On 02/27/02 the reporting person was granted an option to purchase 15,000 shares of the Issuer's Common Stock at a purchase price of $22.05 per share. This option had an exercise price which was less than the closing price of the company's common stock on the appropriate measurement date determined by a special committee of the company's Board of Directors and the Company for financial accounting purposes. The Company has agreed to amend the outstanding portion of the misdated option to increase the exercise price to the appropriate fair market value per share on the correct measurement date ($25.53) so as to avoid adverse tax consequences under Internal Revenue Code 409A, and as applicable, similar provisions of state law. The Company and the reporting person entered into a Stock Option Amendment and Special Bonus Agreement to amend this option. F1 · price: On 02/27/02 the reporting person was granted an option to purchase 15,000 shares of the Issuer's Common Stock at a purchase price of $22.05 per share. This option had an exercise price which was less than the closing price of the company's common stock on the appropriate measurement date determined by a special committee of the company's Board of Directors and the Company for financial accounting purposes. The Company has agreed to amend the outstanding portion of the misdated option to increase the exercise price to the appropriate fair market value per share on the correct measurement date ($25.53) so as to avoid adverse tax consequences under Internal Revenue Code 409A, and as applicable, similar provisions of state law. The Company and the reporting person entered into a Stock Option Amendment and Special Bonus Agreement to amend this option. F3 · price: In exchange for increasing the exercise price of this misdated option, the company agreed to make a cash payment in January of 2009 to the reporting person, in order to make such reporting person whole for the incremental exercise price increase. The amount of the cash payment is expected to be $12,180. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.